The Role of Decavanadate in Anti- Tumour Activity
Journal: Global Journal of Cancer Therapy (Vol.3, No. 1)Publication Date: 2017-12-30
Authors : M Aureliano;
Page : 012-014
Keywords : Decavanadate; Anticancer; Polyoxometa- lates (Poms);
Abstract
Decavanadate compounds were described to be involved in a variety of biological activities and responses such as anti-virus, anti-bacterial and anticancer. While the mechanisms of action of the antiviral and anti-bacterial activities are better understood, the same does not go for the anti-tumour activity. Nevertheless, the inhibition of tumour proliferation seems to impact certain enzymes such as alkaline phosphatase, ecto-nucleotidases or P-type ATPases. In the present report, several studies are described, in a way to explain the increasing interest of these polyoxometalate in cancer therapy. The detailed knowledge of the molecular basis of decavanadate–proteins and cellular interactions allows to better understand the processes associated with the anticancer applications, not only for decavanadate but as well for other polyoxometalates (POMs).
Other Latest Articles
- Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language
- Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients
- Primary Spindle Cell Rhabdomyosarcoma of Prostate: A Case Report with Review of Literature
- The Paradoxes of Neoantigenes in Predicting Better Prognosis of Cancer Patients
- Gamma-Delta T Cell Acute Lymphoblastic Leukemia: A Single-Center Experience
Last modified: 2018-10-05 21:06:21